Drug Delivery Partnering Terms and Agreements in Pharma and Biotech, 2nd edition


November 1, 2010
408 Pages - SKU: WWV2873682
License type:
Table of Contents Search inside this report Related Reports
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Overview of drug delivery dealmaking
2.1. Introduction
2.2. The anatomy of drug delivery partnering
2.3. Drug delivery or specialty pharma?
2.3.1. Is specialty pharma the only way for drug delivery?
2.3.2. Best practice for optimizing drug delivery program development
2.2.3. The anatomy of a drug delivery deal
2.2.3.a. Case study 1: Alpharma - Durect - September 2008
2.2.3.b. Case study 2: Bayer - MDRNA - August 2007
2.2.3.c. Case study 3: Aradigm - Lung Rx - August 2007
Chapter 3 - Trends in drug delivery dealmaking
3.1. Introduction
3.2. Drug delivery partnering since 2000
3.3. Most active drug delivery dealmakers
3.4. Bigpharma drug delivery dealmaking activity
3.5. Bigpharma not active in drug delivery
3.6. Drug delivery partnering by deal type
3.6.1. Option and evaluation drug delivery partnering
3.7. Drug delivery partnering by disease type
3.8. Drug delivery M&A activity since 2000
Chapter 4 - Leading drug delivery deals
4.1. Introduction
4.2. Top drug delivery deals by value
4.3. Top drug delivery involving bigpharma
4.4. Leading drug delivery M&A deals by value
Chapter 5 - Bigpharma drug delivery deals
5.1. Introduction
5.2. How to use bigpharma drug delivery partnering deals
5.3. Bigpharma partnering company profiles
Abbott
Actavis
Alcon Labs
Allergan
Amgen
Amgen
Apotex
Astellas
AstraZeneca
Baxter International
Bayer
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Cephalon
Chugai
CSL
Daiichi Sankyo
Dainippon Sumitomo
Eisai
Eli Lilly
Forest Laboratories
Genzyme
Gilead Sciences
GlaxoSmithKline
Hospira
Johnson & Johnson
King
Kyowa Hakko Kirin
Lundbeck
Meda
Menarini
Merck & Co
Merck KGaA
Mitsubishi
Mylan
Novartis
Novo Nordisk
Nycomed Pharma
Otsuka
Pfizer
Ratiopharm
Roche
Sanofi-Aventis
Servier
Shionogi
Shire
Takeda
Teva
UCB
Watson
Chapter 6 - Drug delivery company deals
6.1. Introduction
6.2. How to use drug delivery company partnering deals
6.3. Drug delivery partnering company profiles
3M Drug Delivery Systems
Alkermes
Altea Pharmaceuticals
Alza
Aradigm
Bioject
Biovail
Cardinal Health
Cima Labs
Connetics
Cydex Pharmaceuticals
Depomed
Dor Biopharma
Durect
Emisphere
Enzon
Ethypharm
Eurand
Generex
Inovio (formerly Genetronics)
Ivax
Macrochem
Macromed
MDRNA (formerly Nastech)
Nektar
Nexmed
Noven
Penwest
Pherin Pharmaceuticals
Psivida
QLT
Skyepharma
Watson Pharmaceuticals
Zogenix
Chapter 7 - Drug delivery dealmaking directory 2003-2010
7.1. Introduction
7.2. Company A-Z
7.3. By stage of development
Discovery
Pre-clinical
Phase I
Phase II
Phase III
Registration
Marketed
7.4. By deal type
Asset and product purchase
Collaborative R&D
Co-development
Co-marketing
Co-promotion
Development
Distribution
Joint venture
Licensing
M&A
Manufacturing
Marketing
Promotion
Option
Research
Supply
7.5. By therapy area
Cardiovascular
Central nervous system
Dermatology
Gastrointestinal
Genitourinary
Hematology
Immunology
Infection
Inflammation
Metabolic
Musculoskeletal
Oncology
Ophthalmics
Respiratory
Animal health
Chapter 8 - Drug delivery partnering resource center
8.1. Online drug delivery partnering
8.2. Drug delivery partnering events
8.3. Further reading on drug delivery dealmaking
Appendices
Appendix 1 - Deal type definitions
Appendix 2 - Example drug delivery partnering agreement
About CurrentPartnering
Recent titles from CurrentPartnering
Figures in report
Figure 1: Components of the typical drug delivery deal structure
Figure 2: Best practice for drug delivery program development
Figure 3: Drug delivery partnering since 2000
Figure 4: Most active drug delivery dealmakers 2003-2010
Figure 5: Most active bigpharma signing drug delivery deals 2003-2010
Figure 6: Bigpharma - top 50 - drug delivery deals 2003 to 2010
Figure 7: Inactive bigpharma in drug delivery dealmaking 2003-2010
Figure 8: Drug delivery partnering by deal type since 2003
Figure 9: Drug delivery option deals since 2003
Figure 10: Drug delivery partnering by disease type from 2003
Figure 11: Drug delivery M&A since 2000
Figure 12: Top drug delivery deals by value since 2000
Figure 13: Top drug delivery deals signed by bigpharma value since 2000
Figure 14: Top drug delivery M&A deals by value since 2000
Figure 15: Online partnering resources
Figure 16: Forthcoming partnering events
Figure 17: Deal type definitions
Figure 18: Drug delivery partnering agreement between Solvay and Depomed, November 2008
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Drug Delivery Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!